Weight-loss drugs, peptides, I. V. F. As sharps migrate out of doctors’ offices, even needle-phobics are willing to embrace shots. Source: New York Times Top Stories · Summarized by HeadlinesBriefing Related articles'Why not take advantage?' - did hydration breaks spark England comeback?Have GLP-1 Drugs Changed How You Travel? Tell Us About It.Botched final play sees Luka hesitate, LeBron missAmazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D PatientsEngland booed off after limp Japan defeatMore from New York Times Top StoriesOutside ChanceGina Hinojosa Believes She’s the One Who Can Finally Flip TexasLooting Left Damage and Fear on Paradise Street in MarseilleHow Vivek Ramaswamy’s Ruthless Ad in Ohio Divided Republicans5 Takeaways From Our Investigation of Trump’s Waivers for PollutersLatest in Public MarketsFrench government and corporate bond yields are converging · Financial Times MarketsModerna Investors Should Brace for More Whiplash · Wall Street Journal MarketsAttention, Passengers: High Airfares May Be Here to Stay · New York Times BusinessMauritius Carrier Looks at Narrow-Body Jets in Fleet Overhaul · Bloomberg MarketsOdd Lots: How to Run a Restaurant For Three Decades (Podcast) · Bloomberg MarketsRelated briefingsMarkets 24-Hour BriefingMarkets 8-Hour BriefingHomePublic MarketsPeptides, GLP-1 Drugs and Botox: Needles Are Everywhere NowSectionsHomePublic MarketsPrivate MarketsTech & GamesMobileDeveloperF1Sports